Malaria Surveillance

Uses

Risks & contraindications

Evidence quality

Where it comes from

Other

Highlighted claims

• The review examines current practices, barriers, facilitators, and evidence on malaria data reporting by community pharmacies and over-the-counter medicine sellers in sub-Saharan Africa. — Facilitators and barriers to malaria surveillance in community pharmacies and over-the-counter medicine sellers in sub-Saharan Africa’s health sector: a scoping review protocol
• The WHO T3 framework requires healthcare providers, including private-sector providers, to document and report every managed malaria case. — Facilitators and barriers to malaria surveillance in community pharmacies and over-the-counter medicine sellers in sub-Saharan Africa’s health sector: a scoping review protocol
• Private-sector malaria data reporting to national surveillance systems is estimated at only 15.3% in West Africa. — Facilitators and barriers to malaria surveillance in community pharmacies and over-the-counter medicine sellers in sub-Saharan Africa’s health sector: a scoping review protocol
• Robust real-time malaria case tracking is needed across public and private care-seeking points in sub-Saharan Africa. — Facilitators and barriers to malaria surveillance in community pharmacies and over-the-counter medicine sellers in sub-Saharan Africa’s health sector: a scoping review protocol
• Most national malaria surveillance systems in sub-Saharan Africa draw data mainly from government and faith-based facilities. — Facilitators and barriers to malaria surveillance in community pharmacies and over-the-counter medicine sellers in sub-Saharan Africa’s health sector: a scoping review protocol
• Incomplete integration of private-sector data creates a major blind spot in malaria case counts and weakens elimination strategies. — Facilitators and barriers to malaria surveillance in community pharmacies and over-the-counter medicine sellers in sub-Saharan Africa’s health sector: a scoping review protocol